DKSH has expanded the partnership with pharmaceutical company iNova to promote their products in Singapore.
Media release
Singapore, June 16, 2020 – DKSH launched a new partnership in Singapore with iNova Pharmaceuticals. The partner company is an international organization that develops, markets and sells a wide range of prescription medicines and over-the-counter consumer health products in over 20 countries across Asia Pacific and Africa.
DKSH will manage the brand Dequadin, a pharyngeal lozenge and confectionery brand for iNova. Through this expansion, both parties aim to increase the brand penetration in Singapore.
“DKSH and iNova share the vision to help patients get reliable and efficient access to the best healthcare possible. With our local marketing and sales capabilities, DKSH will expand the brand in Singapore,” said Dr. Varun Sethi, Vice President, DKSH Business Unit Healthcare, Southeast Asia & Vietnam.
Sacha Ernst, President, Asia for iNova Pharmaceuticals, added: “We are happy to build on our existing partnership with DKSH and look forward to re-launch Dequadin in Singapore”.
For further information, please contact:
DKSH Singapore
Sabrina Ng
Manager, Branding and Communications
Phone +65 6471 1466
sabrina.hm.ng@dksh.com